Don't ignore the market's bearish action, led by Nvidia, even as Meta and a few other stocks flashed buy signals. Tesla held ...

BTIG analyst Ryan Zimmerman reiterated a Buy rating on Globus Medical (GMED – Research Report) today and set a price target of $91.00. The ...

Biotech stock GeneDx broke out after the FDA issued its first AI rules for medical devices. Globus Medical and GeneDx are in ...

Jefferies analyst Matthew Taylor maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

Everence Capital Management Inc. purchased a new position in Globus Medical, Inc. (NYSE:GMED – Free Report) during the fourth ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Globus said it will offer 33 unique itineraries to Italy in 2025, covering 13 regions, 99 cities and several travel styles.

Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari ...

This leading medical device maker is showing constructive action in a flat base and setting up for its next move.

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Globus Medical Inc is a medical device company ... This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled ...